When was Ultragreen founded?

Ultragreen was founded in 2024 and raised its 1st funding round 1 year after it was founded.

Where is Ultragreen located?

Ultragreen is headquartered in Singapore, Singapore.

Who is the current CEO of Ultragreen?

Ravinder Sajwan of Ultragreen. They have also founded 1 company.

How many employees does Ultragreen have?

As of Jan 31, 2026, the latest employee count at Ultragreen is 100.

Is Ultragreen a funded company?

Ultragreen is a funded company, having raised a total of $188M in its 1st and only funding round, a Series D round on Sep 15, 2025.

When was the latest funding round of Ultragreen?

Ultragreen's latest funding was a $188M Series D round on Sep 15, 2025, with participation from 3 investors.

Is Ultragreen a Diversified Medical Devices company?

The primary sectors of Ultragreen are Diversified Medical Devices and Surgical Instruments.

Where does Ultragreen rank among its competitors?

Ultragreen ranks 50th amongst 1895 active competitors, of which 143 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was Ultragreen, which secured $188M in Sep, 2025.

Who are the top competitors of Ultragreen?

Ultragreen's top competitors include Boston Scientific, Abbott and Medtronic. Among them, Ultragreen secured the most recent funding round in September, 2025.

Ultragreen - 2026 Company Profile, Team, Funding & Competitors

Sectors and market segments that Ultragreen operate in

Ultragreen serves in the Healthcare, Life Sciences market segments.The primary business model of Ultragreen are:

Company Details

Developer of fluorescence imaging systems and AI-powered quantification software. The company provides tools for surgical visualization and data analysis. Its offerings include formulations, imaging hardware, and data ecosystems. The company focuses on advancing technologies designed to broaden clinical applications.

Key Metrics

Founded Year

2024

Location

Singapore, Singapore

Stage

Public

Total Funding

$188M in 1 round

Latest Funding Round

Series D, Sep 15, 2025, $188M

Investors

Vitruvian Partners & 2 more

Ranked

50^th among 1895 active competitors

Employee Count

100 as on Jan 31, 2026

Investment & Acquisitions

Ihldhospital

Similar Companies

Augmedics & 177 more

Exit Details

Public

View Ultragreen's full profile

Ultragreen got listed on Dec 03, 2025.

Click here to take a look at Ultragreen's IPO in detail

Ultragreen has raised a total funding of $188M over 1 round. Its latest funding round was a Series D round on Sep 15, 2025 for $188M. 3 investors participated in its latest round. Ultragreen has 3 institutional investors.

Here is the list of recent funding rounds of Ultragreen:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Sep 15, 2025	$188M	Series D	-	-	65 Equity Partners, Vitruvian Partners	August Global Partners

Access funding benchmarks and valuations. Sign up today!

View details of Ultragreen's funding rounds and investors

The founders of Ultragreen is Ravinder Sajwan. Ravinder Sajwan is the CEO of Ultragreen.

Here are the details of Ultragreen's key team members:

Ravinder Sajwan: Founder & CEO of Ultragreen.
Contact Info: 1 email address

View details of Ultragreen's Founder profiles and Board Members

Ultragreen's employee count trend

Ultragreen has 100 employees as of Jan 26. Here is Ultragreen's employee count trend over the years:

Uncover Ultragreen's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Ultragreen include Boston Scientific, Abbott and Medtronic. Here is the list of Top 10 competitors of Ultragreen, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Boston Scientific 1979, Marlborough (United States), Public	Wide range of medical devices	-	JANA Partners, Endeavour Vision & 10 others	81/100
2nd	Abbott 1888, Libertyville (United States), Public	Developer of medical devices, generic pharmaceuticals, and nutrition products	-	MSN Laboratories, Digital Pharma Lab & 12 others	80/100
3rd	Medtronic 1949, Minneapolis (United States), Public	Developer of medical equipment for chronic diseases	-	Saints Capital, Greyrock Investments & 27 others	80/100
4th	Augmedics 2014, Yokneam Illit (Israel), Series D	Provider of an augmented reality guidance system for surgery	$143M	Terra Venture Partners, AO Invest & 13 others	70/100
5th	Danaher 1969, Washington, DC (United States), Public	R&D company focused on manufacturing dental equipment for multiple therapeutic areas	-	Ventana Capital Management, Bank of America	69/100
6th	Baxter 1931, Deerfield (United States), Acquired	Provides biosciences, medication delivery and renal products	-	Triodos Investment Management, Tekla Capital Management ... & 7 others	68/100
7th	Trivitron 1997, Chennai (India), Series C	Provider of medical technology and devices for healthcare industry needs	$109M	Fidelity Investments, True North & 21 others	68/100
8th	Stryker 1941, Kalamazoo (United States), Acquired	Manufacturer of 3D-printed orthopedic products	-	Gefinor Capital, Castle Investment Management ... & 6 others	66/100
9th	SAGE Therapeutics 1971, Boston (United States), Acquired	Developer of drug candidates for the treatment of rare CNS disorders	$106M	Foresite Capital, Orbimed & 12 others	66/100
10th	HOYA 1941, Shinjuku (Japan), Public	Developer of a wide range of medical devices	-	-	66/100
50th	Ultragreen 2024, Singapore (Singapore), Public	Developer of fluorescence imaging systems and AI-powered quantification software	$188M	Vitruvian Partners, 65 Equity Partners & 1 others	48/100